268 related articles for article (PubMed ID: 12890292)
1. The pharmacokinetics of the interstitial space in humans.
Levitt DG
BMC Clin Pharmacol; 2003 Jul; 3():3. PubMed ID: 12890292
[TBL] [Abstract][Full Text] [Related]
2. PKQuest: capillary permeability limitation and plasma protein binding - application to human inulin, dicloxacillin and ceftriaxone pharmacokinetics.
Levitt DG
BMC Clin Pharmacol; 2002 Sep; 2():7. PubMed ID: 12323078
[TBL] [Abstract][Full Text] [Related]
3. PKQuest: PBPK modeling of highly lipid soluble and extracellular solutes.
Levitt DG
ADMET DMPK; 2019; 7(1):60-75. PubMed ID: 35350744
[TBL] [Abstract][Full Text] [Related]
4. PKQuest: volatile solutes - application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics.
Levitt DG
BMC Anesthesiol; 2002 Aug; 2(1):5. PubMed ID: 12182764
[TBL] [Abstract][Full Text] [Related]
5. PKQuest_Java: free, interactive physiologically based pharmacokinetic software package and tutorial.
Levitt DG
BMC Res Notes; 2009 Aug; 2():158. PubMed ID: 19656378
[TBL] [Abstract][Full Text] [Related]
6. PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.
Levitt DG
BMC Clin Pharmacol; 2002 Aug; 2():5. PubMed ID: 12182760
[TBL] [Abstract][Full Text] [Related]
7. Physiologically based pharmacokinetic modeling of arterial - antecubital vein concentration difference.
Levitt DG
BMC Clin Pharmacol; 2004 Feb; 4():2. PubMed ID: 15053829
[TBL] [Abstract][Full Text] [Related]
8. Human physiologically based pharmacokinetic model for propofol.
Levitt DG; Schnider TW
BMC Anesthesiol; 2005 Apr; 5(1):4. PubMed ID: 15847680
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
Edginton AN; Schmitt W; Willmann S
Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
[TBL] [Abstract][Full Text] [Related]
10. Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approaches.
Eigenmann MJ; Karlsen TV; Krippendorff BF; Tenstad O; Fronton L; Otteneder MB; Wiig H
J Physiol; 2017 Dec; 595(24):7311-7330. PubMed ID: 28960303
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of antibiotics in tissues and tissue fluids: a review.
Cars O
Scand J Infect Dis Suppl; 1990; 74():23-33. PubMed ID: 2097711
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans.
Ryan DM
J Antimicrob Chemother; 1993 May; 31 Suppl D():1-16. PubMed ID: 8335512
[TBL] [Abstract][Full Text] [Related]
13. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
[TBL] [Abstract][Full Text] [Related]
14. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
Ye M; Nagar S; Korzekwa K
Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of interstitial fluid space demonstrated by simultaneous kinetic analysis of the distribution and elimination of inulin and gallamine.
Henthorn TK; Avram MJ; Frederiksen MC; Atkinson AJ
J Pharmacol Exp Ther; 1982 Aug; 222(2):389-94. PubMed ID: 7097559
[TBL] [Abstract][Full Text] [Related]
16. An application of microdialysis to drug tissue distribution study: in vivo evidence for free-ligand hypothesis and tissue binding of beta-lactam antibiotics in interstitial fluids.
DeGuchi Y; Terasaki T; Yamada H; Tsuji A
J Pharmacobiodyn; 1992 Feb; 15(2):79-89. PubMed ID: 1403606
[TBL] [Abstract][Full Text] [Related]
17. Effect of extracellular water volume on the distribution kinetics of beta-lactam antibiotics as a function of age.
Tsuji A; Terasaki T; Imaeda N; Nishide K; Nakashima E
J Pharmacobiodyn; 1985 Mar; 8(3):167-74. PubMed ID: 4009409
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
Tsuji A; Nishide K; Minami H; Nakashima E; Terasaki T; Yamana T
Drug Metab Dispos; 1985; 13(6):729-39. PubMed ID: 2867880
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the interaction between interstitial plasma protein, interstitial flow, and fenestral filtration and its application to synovium.
Levick JR
Microvasc Res; 1994 Jan; 47(1):90-125. PubMed ID: 8022316
[TBL] [Abstract][Full Text] [Related]
20. A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug design.
Poulin P
J Pharm Sci; 2015 Jul; 104(7):2359-68. PubMed ID: 25943586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
